When you buy through links on our articles, Future and its syndication partners may earn a commission. MRNA technology was thrust into the limelight during the COVID-19 pandemic, but had been in ...
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...
AUSTIN (KXAN) — We’re learning more about exactly how the Pfizer COVID-19 vaccine works from research scientists at the University of Texas at Austin who helped develop it. “The way the Pfizer vaccine ...
Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...
Hosted on MSN
UPenn, where mRNA vaccine tech was pioneered, will not lose funding as feds cut $500M in mRNA grants
Researchers in Philadelphia reacted with alarm this week when the Department of Health and Human Services announced that it is cutting $500 million in funding for mRNA vaccine development. But the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback